Plimoth Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.58M | Buy |
26,002
+668
| +3% | +$38.9K | 0.35% | 71 |
|
|
2025
Q4 | $1.37M | Sell |
25,334
-400
| -2% | -$19.2K | 0.3% | 77 |
|
|
2025
Q3 | $1.16M | Sell |
25,734
-1,545
| -6% | -$72.2K | 0.26% | 83 |
|
|
2025
Q2 | $1.26M | Sell |
27,279
-260
| -0.9% | -$12.8K | 0.3% | 79 |
|
|
2025
Q1 | $1.68M | Sell |
27,539
-2,225
| -7% | -$130K | 0.44% | 69 |
|
|
2024
Q4 | $1.68M | Sell |
29,764
-390
| -1% | -$21.8K | 0.43% | 66 |
|
|
2024
Q3 | $1.56M | Sell |
30,154
-1,500
| -5% | -$70.4K | 0.39% | 70 |
|
|
2024
Q2 | $1.31M | Sell |
31,654
-23
| -0.1% | -$1.03K | 0.35% | 75 |
|
|
2024
Q1 | $1.72M | Sell |
31,677
-460
| -1% | -$23.4K | 0.46% | 65 |
|
|
2023
Q4 | $1.65M | Sell |
32,137
-1,015
| -3% | -$53.3K | 0.48% | 63 |
|
|
2023
Q3 | $1.92M | Sell |
33,152
-715
| -2% | -$43.8K | 0.6% | 58 |
|
|
2023
Q2 | $2.17M | Sell |
33,867
-1,050
| -3% | -$70.4K | 0.65% | 55 |
|
|
2023
Q1 | $2.42M | Sell |
34,917
-322
| -0.9% | -$22.7K | 0.75% | 49 |
|
|
2022
Q4 | $2.54M | Sell |
35,239
-961
| -3% | -$72.5K | 0.82% | 44 |
|
|
2022
Q3 | $2.57M | Sell |
36,200
-699
| -2% | -$50.7K | 0.89% | 36 |
|
|
2022
Q2 | $2.84M | Sell |
36,899
-25,612
| -41% | -$1.95M | 0.9% | 38 |
|
|
2022
Q1 | $4.57M | Sell |
62,511
-638
| -1% | -$42.8K | 1.21% | 21 |
|
|
2021
Q4 | $3.94M | Buy |
63,149
+5,860
| +10% | +$344K | 1% | 29 |
|
|
2021
Q3 | $3.39M | Buy |
57,289
+133
| +0.2% | +$8.76K | 0.96% | 30 |
|
|
2021
Q2 | $3.82M | Sell |
57,156
-1,558
| -3% | -$102K | 1.07% | 27 |
|
|
2021
Q1 | $3.71M | Buy |
58,714
+2,866
| +5% | +$178K | 1.09% | 24 |
|
|
2020
Q4 | $3.46M | Sell |
55,848
-1,230
| -2% | -$75.6K | 1.08% | 28 |
|
|
2020
Q3 | $3.44M | Buy |
57,078
+4,919
| +9% | +$296K | 1.15% | 24 |
|
|
2020
Q2 | $3.07M | Buy |
52,159
+5,318
| +11% | +$318K | 1.09% | 25 |
|
|
2020
Q1 | $2.61M | Buy |
46,841
+1,227
| +3% | +$75K | 1.09% | 23 |
|
|
2019
Q4 | $2.93M | Sell |
45,614
-679
| -1% | -$38.9K | 0.95% | 28 |
|
|
2019
Q3 | $2.35M | Buy |
46,293
+510
| +1% | +$24K | 0.77% | 36 |
|
|
2019
Q2 | $2.08M | Buy |
45,783
+2,250
| +5% | +$105K | 0.68% | 47 |
|
|
2019
Q1 | $2.08M | Buy |
43,533
+2,990
| +7% | +$149K | 0.69% | 46 |
|
|
2018
Q4 | $2.11M | Sell |
40,543
-410
| -1% | -$22K | 0.78% | 37 |
|
|
2018
Q3 | $2.54M | Sell |
40,953
-2,327
| -5% | -$138K | 0.82% | 35 |
|
|
2018
Q2 | $2.4M | Sell |
43,280
-795
| -2% | -$42.9K | 0.82% | 36 |
|
|
2018
Q1 | $2.79M | Sell |
44,075
-469
| -1% | -$30.2K | 0.96% | 28 |
|
|
2017
Q4 | $2.73M | Buy |
+44,544
| New | +$2.79M | 0.98% | 28 |
|
Other funds holding BMY
VCM
VPM
Plimoth Trust's BMY Position: Q1 2026 in Review
Plimoth Trust increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q1 2026, buying an estimated $38.9K and bringing the position to 26,002 shares worth $1.58M. The position accounts for 0.35% of the portfolio, ranked #71.
Plimoth Trust first reported a position in BMY in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.57M in Q1 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Plimoth Trust held 26,002 shares of Bristol-Myers Squibb worth $1.58M as of Q1 2026.
- Plimoth Trust bought 668 Bristol-Myers Squibb shares in Q1 2026, an estimated $38.9K.
- Bristol-Myers Squibb made up 0.35% of Plimoth Trust's portfolio in Q1 2026, its #71 holding.
- Plimoth Trust first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 34 quarters since.
- Plimoth Trust's Bristol-Myers Squibb position peaked at $4.57M in Q1 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.